Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 175 JPY -2.2% Market Closed
Market Cap: 33.4B JPY
Daito Pharmaceutical Co Ltd
/
Income Statement
/
Revenue

Daito Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Revenue
¥47.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
4%
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
¥4.6T
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
¥1.8T
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
¥2.3T
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
¥1.2T
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
¥1.9T
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
4%

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
33.3B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
3 136.71 JPY
Undervaluation 31%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Daito Pharmaceutical Co Ltd's Revenue?
Revenue
47.4B JPY

Based on the financial report for Nov 30, 2024, Daito Pharmaceutical Co Ltd's Revenue amounts to 47.4B JPY.

What is Daito Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
4%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Daito Pharmaceutical Co Ltd have been 2% over the past three years , 1% over the past five years , and 4% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.